Mga Batayang Estadistika
| LEI | 5493005YHWHM3HIYPJ40 |
| CIK | 1618500 |
SEC Filings
All companies that sell securities in the United States must register with the Securities and Exchange Commission (SEC) and file reports on a regular basis.
These reports include company annual reports (10K, 10Q), news updates (8K), investor presentations (found in 8Ks), insider trades (form 4), ownership reports (13D, and 13G), and reports related to the specific securities sold, such as registration statements and prospectus. This page shows recent SEC filings related to Medigus Ltd. - Depositary Receipt (Common Stock)
SEC Filings (Chronological Order)
Halaman ini menyediakan daftar lengkap dan kronologis dari Pengajuan SEC, tidak termasuk pengajuan kepemilikan yang kami sediakan di tempat lain.
| August 22, 2025 |
As filed with the Securities and Exchange Commission on August 22, 2025 As filed with the Securities and Exchange Commission on August 22, 2025 Registration No. |
|
| August 22, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 15 CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. Commission File Number: 001-37381 Xylo Technologies Ltd. (Exact name of registrant as specified in |
|
| August 22, 2025 |
As filed with the Securities and Exchange Commission on August 22, 2025 As filed with the Securities and Exchange Commission on August 22, 2025 Registration No. |
|
| August 22, 2025 |
As filed with the Securities and Exchange Commission on August 22, 2025 As filed with the Securities and Exchange Commission on August 22, 2025 Registration No. |
|
| August 22, 2025 |
As filed with the Securities and Exchange Commission on August 22, 2025 As filed with the Securities and Exchange Commission on August 22, 2025 Registration No. |
|
| August 22, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of August 2025 Commission File Number 001-37381 XYLO TECHNOLOGIES LTD. (Translation of registrant’s name into English) 10 HaNechoshet Street Tel-Aviv, 6971072, Israel (Address of principal executi |
|
| August 22, 2025 |
As filed with the Securities and Exchange Commission on August 22, 2025 As filed with the Securities and Exchange Commission on August 22, 2025 Registration No. |
|
| August 22, 2025 |
As filed with the Securities and Exchange Commission on August 22, 2025 As filed with the Securities and Exchange Commission on August 22, 2025 Registration No. |
|
| August 11, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of August 2025 Commission File Number 001-37381 XYLO TECHNOLOGIES LTD. (Translation of registrant’s name into English) 10 HaNechoshet Street Tel-Aviv, 6971072, Israel (Address of principal executi |
|
| August 8, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of August 2025 Commission File Number 001-37381 XYLO TECHNOLOGIES LTD. (Translation of registrant’s name into English) 10 HaNechoshet Street, Tel-Aviv, 6971072, Israel (Address of principal execut |
|
| June 23, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of June 2025 Commission File Number 001-37381 XYLO TECHNOLOGIES LTD. (Translation of registrant’s name into English) 10 HaNechoshet Street Tel-Aviv, 6971072, Israel (Address of principal executive |
|
| June 5, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of June 2025 Commission File Number 001-37381 XYLO TECHNOLOGIES LTD. (Translation of registrant’s name into English) 10 HaNechoshet Street, Tel-Aviv, 6971072, Israel (Address of principal executiv |
|
| June 5, 2025 |
Xylo Technologies: Viewbix Shares to Begin Trading on Nasdaq Exhibit 99.1 Xylo Technologies: Viewbix Shares to Begin Trading on Nasdaq TEL AVIV, Israel, June 05, 2025 (GLOBE NEWSWIRE) - Xylo Technologies Ltd. (Nasdaq: XYLO) (“Xylo” or the “Company”), a technology-based company engaged in advanced innovative technologies, announced today that Viewbix Inc. (Nasdaq: VBIX), a global developer of ad-tech innovative technologies, has received approval for its sha |
|
| June 4, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of June 2025 Commission File Number 001-37381 XYLO TECHNOLOGIES LTD. (Translation of registrant’s name into English) 10 HaNechoshet Street Tel-Aviv, 6971072, Israel (Address of principal executive |
|
| May 27, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of May 2025 Commission File Number 001-37381 XYLO TECHNOLOGIES LTD. (Translation of registrant’s name into English) 10 HaNechoshet Street Tel-Aviv, 6971072, Israel (Address of principal executive |
|
| April 30, 2025 |
AMENDMENT No. 5 TO LOAN AGREEMENT Exhibit 4.17 AMENDMENT No. 5 TO LOAN AGREEMENT This Amendment No. 5 (“Amendment”) to the Loan Agreement (as defined below) is entered into as of August 22 2024, (“Effective Date”) by and between Xylo Technologies Ltd. (f/k/a Medigus Ltd.), having its principal offices at 10 HaNechoshet St.,Tel Aviv, Israel (the “Lender”), and Gix Internet Ltd. (f/k/a Algomizer Ltd.), a company organized under the |
|
| April 30, 2025 |
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM Exhibit 15.1 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM We consent to the incorporation by reference in the Registration Statement on Form F-3 (File No. 333-271984) and in the Registration Statement on Form S-8 (File No. 333-274190) of our report dated April 30, 2025, relating to the financial statements of Xylo Technologies Ltd. appearing in this Annual Report on Form 20-F for the y |
|
| April 30, 2025 |
Exhibit 4.3 COMPENSATION POLICY XYLO TECHNOLOGEIS LTD. Compensation Policy for Executive Officers and Directors (As Adopted on October 30, 2024) A. Overview and Objectives 1. Introduction This document sets forth the Compensation Policy for Executive Officers and Directors (this “Compensation Policy” or “Policy”) of Xylo Technologies Ltd. (“Xylo” or the “Company”), in accordance with the requireme |
|
| April 30, 2025 |
Exhibit 12.2 CERTIFICATION I, Tali Dinar, certify that: 1. I have reviewed this annual report on Form 20-F of Xylo Technologies Ltd., formerly known as Medigus Ltd.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made |
|
| April 30, 2025 |
Exhibit 13.2 CERTIFICATION PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (SUBSECTIONS (a) AND (b) OF SECTION 1350, CHAPTER 63 OF TITLE 18, UNITED STATES CODE) Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (Subsections (a) and (b) of Section 1350, Chapter 63 of Title 18, United States Code), the undersigned officer of Xylo Technologies Ltd., formerly known as Medigus Ltd., a |
|
| April 30, 2025 |
Exhibit 99.1 Xylo Technologies: Charging Robotics Successfully Installs Wireless EV Charging System in Automatic Parking Facility TEL AVIV, Israel, April 30, 2025 (GLOBE NEWSWIRE) - Xylo Technologies Ltd. (Nasdaq: XYLO) (“Xylo” or the “Company”), a technology-based company engaged in advanced innovative technologies, announced today that Charging Robotics, Inc. (OTC: CHEV) (“Charging Robotics”), a |
|
| April 30, 2025 |
Xylo Technologies Ltd. Insider Trading Policy (Adopted on December 29, 2024) Exhibit 11.1 Xylo Technologies Ltd. Insider Trading Policy (Adopted on December 29, 2024) Contents Page I. Summary 2 II. Statement of Policies Prohibiting Insider Trading 3 III. Explanation of Insider Trading 4 IV. Statement of Procedures to Prevent Insider Trading 7 V. Additional Prohibited Transactions 9 VI. Rule 10b5-1 Trading Plans 10 Insider Trading Compliance Policy U.S. federal securities l |
|
| April 30, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of April 2025 Commission File Number 001-37381 XYLO TECHNOLOGIES LTD. (Translation of registrant’s name into English) 10 HaNechoshet Street, Tel-Aviv, 6971072, Israel (Address of principal executi |
|
| April 30, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 20-F ☐ REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE FISCAL YEAR ENDED DECEMBER 31, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT O |
|
| April 30, 2025 |
AMENDMENT No. 6 TO THE LOAN AGREEMENT Exhibit 4.18 AMENDMENT No. 6 TO THE LOAN AGREEMENT This Amendment No. 6 (“Amendment”) to the Loan Agreement (as defined below) is entered into as of October 6, 2024 (“Effective Date”) by and between Xylo Technologies Ltd. (f/k/a Medigus Ltd.), having its principal offices at 10 HaNechoshet St.,Tel Aviv, Israel (the “Lender”), and Gix Internet Ltd. (f/k/a Algomizer Ltd.), a company organized under |
|
| April 30, 2025 |
AMENDMENT No. 7 TO LOAN AGREEMENT Exhibit 4.19 AMENDMENT No. 7 TO LOAN AGREEMENT This Amendment No. 7 (“Amendment”) to the Loan Agreement (as defined below) is entered into as of January 6, 2025, (the “Effective Date”) by and between Xylo Technologies Ltd. (f/k/a Medigus Ltd.), having its principal offices at 10 HaNechoshet St.,Tel Aviv, Israel (the “Lender”), and Gix Internet Ltd. (f/k/a Algomizer Ltd.), a company organized under |
|
| April 30, 2025 |
Exhibit 13.1 CERTIFICATION PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (SUBSECTIONS (a) AND (b) OF SECTION 1350, CHAPTER 63 OF TITLE 18, UNITED STATES CODE) Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (Subsections (a) and (b) of Section 1350, Chapter 63 of Title 18, United States Code), the undersigned officer of Xylo Technologies Ltd., formerly known as Medigus Ltd., a |
|
| April 30, 2025 |
Exhibit 12.1 CERTIFICATION I, Liron Carmel, certify that: 1. I have reviewed this annual report on Form 20-F of Xylo Technologies Ltd., formerly known as Medigus Ltd.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were ma |
|
| April 29, 2025 |
Xylo Technologies: Revoltz Secures First Institutional Client for PORTO EV Logistics Deployment Exhibit 99.1 Xylo Technologies: Revoltz Secures First Institutional Client for PORTO EV Logistics Deployment TEL AVIV, Israel, April 29, 2025 (GLOBE NEWSWIRE) - Xylo Technologies Ltd. (Nasdaq: XYLO) (“Xylo” or the “Company”), a technology-based company engaged in advanced innovative technologies, announced today that Revoltz Ltd. (“Revoltz”), which is 19.9% held by Charging Robotics, Inc. (OTC: CH |
|
| April 29, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of April 2025 Commission File Number 001-37381 XYLO TECHNOLOGIES LTD. (Translation of registrant’s name into English) 10 HaNechoshet Street, Tel-Aviv, 6971072, Israel (Address of principal executi |
|
| April 21, 2025 |
XYLO TECHNOLOGIES LTD. PROXY CARD THIS PROXY IS SOLICITED ON BEHALF OF THE BOARD OF DIRECTORS Exhibit 99.3 XYLO TECHNOLOGIES LTD. PROXY CARD THIS PROXY IS SOLICITED ON BEHALF OF THE BOARD OF DIRECTORS The undersigned hereby appoints, Mr. Liron Carmel, the Company’s Chief Executive Officer, and Ms. Tali Dinar, the Company’s Chief Financial Officer, each of them, agents and proxies of the undersigned, with full power of substitution to each of them, to represent and to vote on behalf of the |
|
| April 21, 2025 |
Exhibit 99.2 PLEASE BE SURE TO SIGN AND DATE THIS PROXY CARD AND MARK ON THE REVERSE SIDE Copyright © 2025 BetaNXT, Inc. or its affiliates. All Rights Reserved YOUR VOTE IS IMPORTANT! PLEASE VOTE BY: 12:00 p.m. E.T. on May 22, 2025 Xylo Technologies Ltd. Instructions to The Bank of New York Mellon, as Depositary (Must be received prior to 12:00 p.m. E.T. on May 22, 2025) The undersigned registered |
|
| April 21, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of April 2025 Commission File Number 001-37381 XYLO TECHNOLOGIES LTD. (Translation of registrant’s name into English) 10 HaNechoshet Street Tel-Aviv, 6971072, Israel (Address of principal executiv |
|
| April 21, 2025 |
NOTICE OF SPECIAL MEETINGS OF THE SHAREHOLDERS OF XYLO TECHNOLOGIES LTD. to be held on May 27, 2025 Exhibit 99.1 Dear Shareholders: I am writing to you today about the proposed scheme of arrangement (“Arrangement”) between Xylo Technologies Ltd. (“Xylo” or the “Company”) and its existing shareholders as of the effective time of the Arrangement. The Arrangement was filed at the request of one of Xylo’s shareholders, L.I.A. Pure Capital Ltd., a company incorporated under the laws of the State of I |
|
| April 17, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of April 2025 Commission File Number 001-37381 XYLO TECHNOLOGIES LTD. (Translation of registrant’s name into English) 10 HaNechoshet Street Tel-Aviv, 6971072, Israel (Address of principal executiv |
|
| April 10, 2025 |
Exhibit 99.1 Xylo Technologies: Revoltz Launches Commercial Phase of PORTO EV in Israel with First 50 Vehicles Delivered to Exclusive Distributor Marks First Global Commercial Rollout of the Innovative Last-Mile Micro EV TEL AVIV, Israel, April 10, 2025 (GLOBE NEWSWIRE) - Xylo Technologies Ltd. (Nasdaq: XYLO) (“Xylo” or the “Company”), a technology-based company engaged in advanced innovative tech |
|
| April 10, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of April 2025 Commission File Number 001-37381 XYLO TECHNOLOGIES LTD. (Translation of registrant’s name into English) 10 HaNechoshet Street, Tel-Aviv, 6971072, Israel (Address of principal executi |
|
| April 9, 2025 |
Xylo Technologies: Revoltz Wins 2025 TAIPEI CYCLE Award for Micro-Mobility Innovation Exhibit 99.1 Xylo Technologies: Revoltz Wins 2025 TAIPEI CYCLE Award for Micro-Mobility Innovation TEL AVIV, Israel, April 09, 2025 (GLOBE NEWSWIRE) - Xylo Technologies Ltd. (Nasdaq: XYLO) (“Xylo” or the “Company”), a technology-based company engaged in advanced innovative technologies, announced today that Revoltz Ltd. (“Revoltz”), which is 19.9% held by Charging Robotics, Inc. (OTC: CHEV) (“Char |
|
| April 9, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of April 2025 Commission File Number 001-37381 XYLO TECHNOLOGIES LTD. (Translation of registrant’s name into English) 10 HaNechoshet Street, Tel-Aviv, 6971072, Israel (Address of principal executi |
|
| March 27, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of March 2025 Commission File Number 001-37381 XYLO TECHNOLOGIES LTD. (Translation of registrant’s name into English) 10 HaNechoshet Street, Tel-Aviv, 6971072, Israel (Address of principal executi |
|
| March 4, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of March 2025 Commission File Number 001-37381 XYLO TECHNOLOGIES LTD. (Translation of registrant’s name into English) 10 HaNechoshet Street, Tel-Aviv 6971072, Israel (Address of principal executiv |
|
| February 18, 2025 |
JFBR / Jeffs' Brands Ltd / Medigus Ltd. - EXECUTIVE OFFICERS AND DIRECTORS OF XYLO TECHNOLOGIES LTD Exhibit 1 ANNEX A Executive Officers and Directors of Xylo Technologies Ltd. Set forth below is the name, current business address, the present principal occupation or employment and citizenship of each director and executive officer of Xylo Technologies Ltd. (“Xylo”). Unless otherwise indicated, each person identified below is employed by Xylo. The principal address of Xylo, and unless otherwise |
|
| February 18, 2025 |
Exhibit 1 JOINT FILING AGREEMENT In accordance with Rule 13d-1(k)(1)(iii) under the Securities Exchange Act of 1934, as amended, the persons named below agree to the joint filing on behalf of each of them of a Statement on Schedule 13D (including additional amendments thereto) with respect to the shares of common stock, par value $0. |
|
| February 18, 2025 |
Exhibit 7.1 JOINT FILING AGREEMENT The undersigned hereby agree that the statement on Schedule 13D with respect to the ordinary shares underlying American Depositary Securities of Xylo Technologies Ltd., dated February 18, 2025, and any further amendments thereto signed by each of the undersigned shall be, filed on behalf of each of the undersigned pursuant to and in accordance with the provisions |
|
| February 4, 2025 |
Xylo Technologies: Revoltz Receives Israeli Standards Institute Approval for PORTO EV Micro Vehicle Exhibit 99.1 Xylo Technologies: Revoltz Receives Israeli Standards Institute Approval for PORTO EV Micro Vehicle TEL AVIV, Israel, Feb. 04, 2025 (GLOBE NEWSWIRE) - Xylo Technologies Ltd. (Nasdaq: XYLO) (“Xylo” or the “Company”), a technology-based company engaged in advanced innovative technologies, announced today that Revoltz Ltd (“Revoltz”), which is 19.9% held by Charging Robotics, Inc. (OTC: |
|
| February 4, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of February 2025 Commission File Number 001-37381 XYLO TECHNOLOGIES LTD. (Translation of registrant’s name into English) 10 HaNechoshet Street, Tel-Aviv, 6971072, Israel (Address of principal exec |
|
| December 30, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of December 2024 Commission File Number 001-37381 XYLO TECHNOLOGIES LTD. (Translation of registrant’s name into English) 10 HaNechoshet Street Tel-Aviv, 6971072, Israel (Address of principal execu |
|
| November 29, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of November 2024 Commission File Number 001-37381 XYLO TECHNOLOGIES LTD. (Translation of registrant’s name into English) 10 HaNechoshet Street Tel-Aviv, 6971072, Israel (Address of principal execu |
|
| November 15, 2024 |
Exhibit 4.1 Form of Pre-Funded Warrant PRE-FUNDED WARRANT TO PURCHASE ORDINARY SHARES REPRESENTED BY AMERICAN DEPOSITARY SHARES XYLO TECHNOLOGIES LTD. Warrant No.: Issue Date: , 2024 Number of American Depositary Shares: THIS PRE-FUNDED WARRANT TO PURCHASE ORDINARY SHARES REPRESENTED BY AMERICAN DEPOSITARY SHARES (the “Warrant”) certifies that, for value received, or its assigns (the “Holder”) is |
|
| November 15, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of November 2024 Commission File Number 001-37381 XYLO TECHNOLOGIES LTD. (Translation of registrant’s name into English) 10 HaNechoshet Street Tel-Aviv, 6971072, Israel (Address of principal execu |
|
| November 15, 2024 |
Pre-Funded Warrants to Purchase up to 454,752 American Depositary Shares Filed Pursuant to Rule 424(b)(5) Registration No. 333-271984 PROSPECTUS SUPPLEMENT (To Prospectus dated May 16, 2023, as amended) Pre-Funded Warrants to Purchase up to 454,752 American Depositary Shares Xylo Technologies Ltd., (the “Company” or “we”) is offering (the “Registered Direct Offering”) Pre-Funded Warrants (“Pre-Funded Warrants”) to purchase up to an aggregate of 454,752 American Deposit |
|
| November 15, 2024 |
Exhibit 10.1 WARRANTS PURCHASE AGREEMENT This Warrants Purchase Agreement (this “Agreement”) is dated as of November 15, 2024, between Xylo Technologies Ltd., a company organized under the laws of Israel (the “Company”), and the purchaser identified on the signature pages hereto (including its successors and assigns, the “Purchaser”). WHEREAS, subject to the terms and conditions set forth in this |
|
| October 31, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of October 2024 Commission File Number 001-37381 XYLO TECHNOLOGIES LTD. (Translation of registrant’s name into English) 10 HaNechoshet Street Tel-Aviv, 6971072, Israel (Address of principal execut |
|
| September 25, 2024 |
Exhibit 99.2 |
|
| September 25, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of September 2024 Commission File Number 001-37381 XYLO TECHNOLOGIES LTD. (Translation of registrant’s name into English) 10 HaNechoshet Street Tel-Aviv, 6971072, Israel (Address of principal exec |
|
| September 25, 2024 |
HaNechoshet 10, Tel-Aviv, 6971072 Exhibit 99.1 HaNechoshet 10, Tel-Aviv, 6971072 Israel Dear Shareholder: September 25, 2024 You are cordially invited to attend the annual general meeting (the “Meeting”) of the shareholders of Xylo Technologies Ltd. (the “Company”), to be held on October 30, 2024, beginning at 5:00 PM, Israel time (10:00 AM Eastern time), at the offices of at the offices of the Company, HaNechoshet 10, Tel-Aviv, 6 |
|
| September 20, 2024 |
Exhibit 99.1 XYLO TECHNOLOGIES LTD INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS AS OF JUNE 30, 2024 TABLE OF CONTENTS Interim Condensed Consolidated Statements of Financial Position 2 to 3 Interim Condensed Consolidated Statements of Loss and Other Comprehensive Income 4 Interim Condensed Consolidated Statements of Changes in Equity 5 to 6 Interim Condensed Consolidated Statements of Cash F |
|
| September 20, 2024 |
Exhibit 99.2 Xylo Technologies Ltd. Operating and Financial Review as of June 30, 2024, and for the six months then ended The information contained in this section should be read in conjunction with (1) our unaudited interim condensed consolidated financial statements as of June 30, 2024, and for the six months then ended and related notes included in this report and (2) our audited consolidated f |
|
| September 20, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of September 2024 Commission File Number 001-37381 XYLO TECHNOLOGIES LTD (Translation of registrant’s name into English) 10 HaNechoshet Street Tel-Aviv, 6971072, Israel (Address of principal execu |
|
| August 15, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of August 2024 Commission File Number 001-37381 XYLO TECHNOLOGIES LTD. (Translation of registrant’s name into English) 10 HaNechoshet Street, Tel-Aviv, 6971072, Israel (Address of principal execut |
|
| August 15, 2024 |
Exhibit 99.1 Xylo Technologies: ParaZero Received Order from a Leading Tier-One Defense Company for 50 Drone Safety Systems TEL AVIV, Israel, Aug. 15, 2024 (GLOBE NEWSWIRE) - Xylo Technologies Ltd. (Nasdaq: XYLO) (“Xylo” or the “Company”), a technology-based company engaged in advanced innovative technologies, announced today that ParaZero Technologies Ltd. (Nasdaq: PRZO) ( “ParaZero”), an aerospa |
|
| August 14, 2024 |
6-K 1 ea0211232-6kxylotech.htm REPORT OF FOREIGN PRIVATE ISSUER UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of August 2024 Commission File Number 001-37381 XYLO TECHNOLOGIES LTD. (Translation of registrant’s name into English) 10 HaNechoshe |
|
| August 14, 2024 |
EX-99.1 2 ea021123201ex99-1xylotech.htm PRESS RELEASE DATED AUGUST 14, 2024 Exhibit 99.1 Xylo Technologies: Revoltz to Launch an Innovative Three-Wheel Electric Cargo Bike for European and UK Markets TEL AVIV, Israel, Aug. 14, 2024 (GLOBE NEWSWIRE) - Xylo Technologies Ltd. (Nasdaq: XYLO) (“Xylo” or the “Company”), a technology-based company engaged in advanced innovative technologies, announced to |
|
| July 30, 2024 |
Xylo Technologies Announces Plan to Implement ADS Ratio Change Exhibit 99.1 Xylo Technologies Announces Plan to Implement ADS Ratio Change Tel Aviv, Israel, July 30, 2024 (GLOBE NEWSWIRE) - Xylo Technologies Ltd. (Nasdaq: XYLO) (“Xylo” and the “Company”), a technology company engaged in advanced medical solutions, innovative internet technologies and electric vehicle (“EV”) and charging solutions, announced today that it plans a ratio change which will result |
|
| July 30, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of July 2024 Commission File Number 001-37381 XYLO TECHNOLOGIES LTD. (Translation of registrant’s name into English) 10 HaNechoshet Street, 6971072, Israel (Address of principal executive offices) |
|
| July 22, 2024 |
424B3 1 xylo424b3.htm 424B3 Rule 424(b)(3) File No. 333-203937 Note: This revised form of American Depositary Receipt is being filed to reflect that the ratio of Shares per American Depositary Share has changed from fifteen to forty shares, effective August 5, 2024. EXHIBIT A AMERICAN DEPOSITARY SHARES (Each American Depositary Share represents forty (40) deposited Shares) THE BANK OF NEW YORK MEL |
|
| June 6, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of June 2024 Commission File Number 001-37381 XYLO TECHNOLOGIES LTD. (Translation of registrant’s name into English) 10 HaNechoshet Street, Tel-Aviv, 6971072, Israel (Address of principal executiv |
|
| June 6, 2024 |
Xylo: Gix Internet Signed MOU for Investment and Merger with an AI- Robotics Company Exhibit 99.1 Xylo: Gix Internet Signed MOU for Investment and Merger with an AI- Robotics Company TEL AVIV, Israel, June 06, 2024 (GLOBE NEWSWIRE) - Xylo Technologies Ltd. (Nasdaq: XYLO) (“Xylo”), a technology-based company engaged in advanced innovative technologies, announced today that Gix Internet Ltd. (“Gix”) (45.75% owned by Xylo) (TASE: GIX), signed a non-binding memorandum of understanding |
|
| May 28, 2024 |
Exhibit 99.1 Xylo: Metagramm Successfully Completes Development of Advanced AI-Powered Writing and Grammar Product The new product offers unique capabilities of custom personalized text writing, different from common AI writing tools. TEL AVIV, Israel, May 28, 2024 (GLOBE NEWSWIRE) - Xylo Technologies Ltd. (Nasdaq: XYLO) (“Xylo”), a technology-based company engaged in advanced innovative technolog |
|
| May 28, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of May 2024 Commission File Number 001-37381 XYLO TECHNOLOGIES LTD. (Translation of registrant’s name into English) 10 HaNechoshet Street, Tel-Aviv, 6971072, Israel (Address of principal executive |
|
| May 21, 2024 |
Xylo Technologies Signs LOI to Acquire a Leading AI Technology Company Based in Germany Exhibit 99.1 Xylo Technologies Signs LOI to Acquire a Leading AI Technology Company Based in Germany TEL AVIV, Israel, May 21, 2024 (GLOBE NEWSWIRE) - Xylo Technologies Ltd. (Nasdaq: XYLO) (“Xylo” or the “Company”), a technology-based company engaged in advanced innovative technologies, announces today it signed a letter of intent (“LOI”) for the strategic acquisition of a leading German company s |
|
| May 21, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of May 2024 Commission File Number 001-37381 XYLO TECHNOLOGIES LTD. (Translation of registrant’s name into English) 10 HaNechoshet Street, Tel-Aviv, 6971072, Israel (Address of principal executive |
|
| May 15, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of May 2024 Commission File Number 001-37381 XYLO TECHNOLOGIES LTD. (Translation of registrant’s name into English) 10 HaNechoshet Street, Tel-Aviv, 6971072, Israel (Address of principal executive |
|
| May 15, 2024 |
Exhibit 99.1 Xylo Technologies: Charging Robotics and Make My Day to Deploy AI based EV Charging Management System TEL AVIV, Israel, May 15, 2024 (GLOBE NEWSWIRE) - Xylo Technologies Ltd. (Nasdaq: XYLO) (“Xylo”), a technology-based company engaged in advanced innovative technologies, announces today that Charging Robotics, Inc. (OTC: FDOCD) (“Charging Robotics”), an innovator of wireless charging |
|
| April 22, 2024 |
Exhibit 12.2 CERTIFICATION I, Tali Dinar, certify that: 1. I have reviewed this annual report on Form 20-F of Xylo Technologies Ltd., formerly known as Medigus Ltd.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made |
|
| April 22, 2024 |
AMENDMENT No. 3 TO THE LOAN AGREEMENT Exhibit 4.10 AMENDMENT No. 3 TO THE LOAN AGREEMENT This Amendment No. 3 (“Amendment”) to the Loan Agreement (as defined below) is entered into as of November 8, 2023 (“Effective Date”) by and between Medigus Ltd., having its principal offices at Omer Industrial Park, No.7A, P.O. Box 3030, Omer 8496500, Israel (the “Lender”), and Gix Internet Ltd. (f/k/a Algomizer Ltd.), a company organized under t |
|
| April 22, 2024 |
Exhibit 4.17 LOAN AGREEMENT This Loan Agreement (“Loan Agreement”) is made effective as of November 15, 2023, by and among Viewbix Ltd., a company organized under the laws of the State of Israel (the “Company”), and the lenders set forth in Schedule I hereto (each, a “Lender”, and collectively, the “Lenders”). NOW, THEREFORE, in consideration of the promises and mutual covenants hereinafter contai |
|
| April 22, 2024 |
Exhibit 4.2 Medigus Ltd. 2023 Share Incentive Plan Unless otherwise defined, terms used herein shall have the meaning ascribed to them in Section 2 hereof. 1. PURPOSE; TYPES OF AWARDS; CONSTRUCTION. 1.1. Purpose. The purpose of this 2023 Share Incentive Plan (as amended, this “Plan”) is to afford an incentive to Service Providers of Medigus Ltd., an Israeli company (together with any successor cor |
|
| April 22, 2024 |
ORDINARY SHARE PURCHASE AGREEMENT Exhibit 4.15 ORDINARY SHARE PURCHASE AGREEMENT THIS ORDINARY SHARE PURCHASE AGREEMENT (this “Agreement”) made as of 20 June, 2023 (the “Effective Date”), by and among Polyrizon Ltd., a company incorporated under the laws of the state of Israel, whose principal address is at 5Hatidhar St., Ra’anana, Israel (the “Company”), Medigus Ltd., a company incorporated under the laws of the state of Israel, |
|
| April 22, 2024 |
AMENDMENT No. 4 TO THE LOAN AGREEMENT Exhibit 4.11 AMENDMENT No. 4 TO THE LOAN AGREEMENT This Amendment No. 4 (“Amendment”) to the Loan Agreement (as defined below) is entered into as of January 1 2024, (“Effective Date”) by and between Medigus Ltd., having its principal offices at 10 HaNechoshet St.,Tel Aviv, Israel (the “Lender”), and Gix Internet Ltd. (f/k/a Algomizer Ltd.), a company organized under the laws of the State of Israel |
|
| April 22, 2024 |
Exhibit 13.2 CERTIFICATION PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (SUBSECTIONS (a) AND (b) OF SECTION 1350, CHAPTER 63 OF TITLE 18, UNITED STATES CODE) Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (Subsections (a) and (b) of Section 1350, Chapter 63 of Title 18, United States Code), the undersigned officer of Xylo Technologies Ltd., formerly known as Medigus Ltd., a |
|
| April 22, 2024 |
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM Exhibit 15.1 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM We consent to the incorporation by reference in the Registration Statement No. 333-271984 on Form F-3 and Registration Statement Nos. 333-206803, 333-221019, 333-229429, 333-258624 and 333-274190 on Form S-8 of our report dated April 22, 2024, relating to the financial statements of Xylo Technologies Ltd., formerly known as Medi |
|
| April 22, 2024 |
Exhibit 12.1 CERTIFICATION I, Liron Carmel, certify that: 1. I have reviewed this annual report on Form 20-F of Xylo Technologies Ltd., formerly known as Medigus Ltd.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were ma |
|
| April 22, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 20-F ☐ REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE FISCAL YEAR ENDED DECEMBER 31, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT O |
|
| April 22, 2024 |
MEDIGUS LTD. POLICY FOR RECOVERY OF ERRONEOUSLY AWARDED COMPENSATION Exhibit 97.1 MEDIGUS LTD. POLICY FOR RECOVERY OF ERRONEOUSLY AWARDED COMPENSATION Medigus Ltd. (the “Company”) has adopted this Policy for Recovery of Erroneously Awarded Compensation (the “Policy”), effective as of October 2, 2023 (the “Effective Date”). Capitalized terms used in this Policy but not otherwise defined herein are defined in Section 11. 1. Persons Subject to Policy This Policy shall |
|
| April 22, 2024 |
Exhibit 4.18 PRIVATE PLACEMENT AGREEMENT THIS PRIVATE PLACEMENT AGREEMENT (this “Agreement”) is made as of the [] day of December 2023, by and between, Gix Internet Ltd., a company organized under the laws of the State of Israel (the “Company”), and MediGus Ltd., a company organized under the laws of the State of Israel (the “Investor” or “Medigus”). The Company and the Investor are referred to co |
|
| April 22, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of April 2024 Commission File Number 001-37381 XYLO TECHNOLOGIES LTD. (Translation of registrant’s name into English) 10 HaNechoshet Street, Tel-Aviv, 6971072, Israel (Address of principal executi |
|
| April 22, 2024 |
AMENDMENT No. 2 TO THE LOAN AGREEMENT Exhibit 4.9 AMENDMENT No. 2 TO THE LOAN AGREEMENT This Amendment No. 2 (“Amendment”) to the Loan Agreement (as defined below) is entered into as of August 29, 2023 with the effective date of July 1 2023 (“Amendment Effective Date”) by and between Medigus Ltd., having its principal offices at Omer Industrial Park, No.7A, P.O. Box 3030, Omer 8496500, Israel (the “Lender”), and Gix Internet Ltd. (f/k |
|
| April 22, 2024 |
Xylo Technologies Files its 2023 Annual Report on Form 20-F Exhibit 99.1 Xylo Technologies Files its 2023 Annual Report on Form 20-F TEL AVIV, Israel, April 22, 2024 (GLOBE NEWSWIRE) - Xylo Technologies Ltd. (Nasdaq: XYLO) (“Xylo”, or the “Company”), formerly known as Medigus Ltd., a technology-based company engaged in advanced innovative technologies, announced the filing of its 2023 Annual Report on Form 20-F with the Securities and Exchange Commission. |
|
| April 22, 2024 |
OPERATING AGREEMENT ZIG MIAMI 54, LLC A FLORIDA LIMITED LIABILITY COMPANY Exhibit 4.16 OPERATING AGREEMENT OF ZIG MIAMI 54, LLC A FLORIDA LIMITED LIABILITY COMPANY This Operating Agreement (this “Agreement”) of ZIG MIAMI 54, LLC, a Florida limited liability company (the “Company”) is entered into as of this 13th day of September 2023 (the “Effective Date”) by and between ZIG INVESTMENT GROUP, LLC, a Florida limited liability company (the “ZIG Member”), MEDIGUS LTD., a c |
|
| April 22, 2024 |
Exhibit 13.1 CERTIFICATION PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (SUBSECTIONS (a) AND (b) OF SECTION 1350, CHAPTER 63 OF TITLE 18, UNITED STATES CODE) Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (Subsections (a) and (b) of Section 1350, Chapter 63 of Title 18, United States Code), the undersigned officer of Xylo Technologies Ltd., formerly known as Medigus Ltd., a |
|
| April 22, 2024 |
Exhibit 1.1 THE COMPANIES LAW, 1999 A LIMITED LIABILITY COMPANY - AMENDED AND RESTATED ARTICLES OF ASSOCIATION OF XYLO TECHNOLOGIES LTD. As Amended on April 1, 2024 Preliminary 1. Definitions; Interpretation. (a) In these Articles, the following terms (whether or not capitalized) shall bear the meanings set forth opposite them, respectively, unless the subject or context requires otherwise. “Affil |
|
| April 22, 2024 |
Exhibit 4.14 Summary of Agreement Note: this summary does not contain a full or direct translation of the terms of the original Hebrew Agreement, and is designated solely for the purpose of providing a general presentation of such Agreement. On April 2, 2023, Medigus Ltd. (the “Investor”) entered into an agreement (the “Agreement”) with Metagramm Software Ltd. (the “Company”) and others (the “Shar |
|
| April 22, 2024 |
Exhibit 2.2 Description of Securities The following description of Xylo Technologies Ltd.’s (the “Company”) share capital, provisions of its amended and restated articles of association as may be amended and restated from time to time, and Israeli law are summaries and do not purport to be complete, and is qualified in its entirety by reference to, the provisions of our amended and restated articl |
|
| April 15, 2024 |
Rule 424(b)(3) File No. 333-203937 Note: Medigus Ltd. has changed its name to Xylo Technologies Ltd. effective April 18, 2024. EXHIBIT A AMERICAN DEPOSITARY SHARES (Each American Depositary Share represents fifteen (15) deposited Shares) THE BANK OF NEW YORK MELLON AMERICAN DEPOSITARY RECEIPT FOR ORDINARY SHARES OF XYLO TECHNOLOGIES LTD. (INCORPORATED UNDER THE LAWS OF ISRAEL) The Bank of New York |
|
| April 15, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of April 2024 Commission File Number: 001-37381 XYLO TECHNOLOGIES LTD. (Translation of registrant’s name into English) 10 HaNechoshet Street, Tel-Aviv, 6971072, Israel (Address of principal execut |
|
| April 9, 2024 |
Exhibit 99.1 Medigus Announces Corporate Rebranding Changes Name to Xylo Technologies Ltd. to Reflect Core Values of its Business Medigus’ Nasdaq trading symbol will change to XYLO on April 18, 2024 Tel Aviv, Israel, April 09, 2024 (GLOBE NEWSWIRE) - Medigus Ltd. (NASDAQ: MDGS) (“Medigus” or the “Company”), a technology-based company engaged in advanced innovative technologies, announced today a c |
|
| April 9, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of April 2024 Commission File Number 001-37381 MEDIGUS LTD. (Translation of registrant’s name into English) 10 HaNechoshet Street, Tel-Aviv, 6971072, Israel (Address of principal executive offices |
|
| March 27, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of March 2024 Commission File Number 001-37381 MEDIGUS LTD. (Translation of registrant’s name into English) 10 HaNechoshet Street, Tel-Aviv, 6971072, Israel (Address of principal executive offices |
|
| March 27, 2024 |
Exhibit 99.1 Medigus: Revoltz Initiates on Exclusive Distribution Agreement of $2.7 Million in Revenues and Completes the Production of the First 50 PORTO Micro-Mobility EVs Following completion of initial production, Revoltz sets up for delivery in accordance with its distribution agreement (the “Agreement”), aiming to sell 150 vehicles in the first year of the Agreement Tel Aviv, Israel, March 2 |
|
| March 19, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of March 2024 Commission File Number 001-37381 MEDIGUS LTD. (Translation of registrant’s name into English) 10 HaNechoshet Street, Tel-Aviv, 6971072, Israel (Address of principal executive offices |
|
| March 19, 2024 |
Exhibit 99.1 Medigus: Charging Robotics Announces Successful Installment of its Wireless Charging System for Automatic Car Parks Tel Aviv, Israel, March 19, 2024 (GLOBE NEWSWIRE) - Medigus Ltd. (Nasdaq: MDGS), a technology-based company engaged in advanced medical solutions, innovative internet technologies, and electric vehicle and charging solutions, announced today that Charging Robotics Ltd. ( |
|
| March 7, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of March 2024 Commission File Number 001-37381 MEDIGUS LTD. (Translation of registrant’s name into English) 10 HaNechoshet Street Tel-Aviv, 6971072, Israel (Address of principal executive offices) |
|
| February 22, 2024 |
Exhibit 99.1 Medigus: ParaZero Ramps Up Partnership with US-Based Autonomous Drone OEM Vayu Aerospace Corporation As part of the ongoing collaboration with Vayu Aerospace, ParaZero’s safety systems will be integrated into Vayu’s fleet of delivery drones Tel Aviv, Israel, Feb. 22, 2024 (GLOBE NEWSWIRE) - Medigus Ltd. (Nasdaq: MDGS), a technology company engaged in electric vehicle charging solution |
|
| February 22, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of February 2024 Commission File Number 001-37381 MEDIGUS LTD. (Translation of registrant’s name into English) 10 HaNechoshet Street, Tel-Aviv, 6971072, Israel (Address of principal executive offi |
|
| February 14, 2024 |
PRZO / ParaZero Technologies Ltd. / Medigus Ltd. - SCHEDULE 13G Passive Investment SC 13G 1 ea193765-13gmedigusparazero.htm SCHEDULE 13G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Act of 1934 ParaZero Technologies Ltd. (Name of Issuer) Ordinary Shares, par value NIS 0.02 per share (Title of Class of Securities) M7S13T102 (CUSIP Number) December 31, 2023 (Date of event which requires filing of this statement) Check th |
|
| February 12, 2024 |
Exhibit 99.2 |
|
| February 12, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of February 2024 Commission File Number 001-37381 MEDIGUS LTD. (Translation of registrant’s name into English) 10 HaNechoshet Street Tel-Aviv, 6971072, Israel (Address of principal executive offic |
|
| February 12, 2024 |
HaNechoshet 10, Tel-Aviv, 6971072 Exhibit 99.1 HaNechoshet 10, Tel-Aviv, 6971072 Israel February 12, 2024 Dear Shareholder: You are cordially invited to attend a special general meeting (the “Meeting”) of the shareholders of Medigus Ltd. (the “Company”), to be held on March 6, 2024, beginning at 5:00 PM, Israel time (10:00 AM Eastern time), at the offices of the Company, HaNechoshet 10, Tel-Aviv, 6971072, Israel, or at any adjourn |
|
| December 27, 2023 |
Exhibit 99.1 Medigus: Charging Robotics Announces Positive Results in Transferring High Voltage Wireless Electricity Needed for EV Charging Tel Aviv, Israel, Dec. 27, 2023 (GLOBE NEWSWIRE) - Medigus Ltd. (Nasdaq: MDGS), a technology company engaged in advanced medical solutions, innovative internet technologies, and electric vehicle and charging solutions, today announced that Charging Robotics Lt |
|
| December 27, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of December 2023 Commission File Number 001-37381 MEDIGUS LTD. (Translation of registrant’s name into English) 10 HaNechoshet Street, Tel-Aviv, 6971072, Israel (Address of principal executive offi |
|
| December 21, 2023 |
Exhibit 99.1 Medigus: ParaZero Successfully Completed its Drone Safety Project with a Fortune 500 Leading Automotive Manufacturer ParaZero is furthering its collaboration with the same esteemed customer, having recently secured an additional order Tel Aviv, Israel, Dec. 21, 2023 (GLOBE NEWSWIRE) - Medigus Ltd. (Nasdaq: MDGS), a technology company engaged in electric vehicle charging solutions, adv |
|
| December 21, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of December 2023 Commission File Number 001-37381 MEDIGUS LTD. (Translation of registrant’s name into English) 10 HaNechoshet Street, Tel-Aviv, 6971072, Israel (Address of principal executive offi |
|
| December 18, 2023 |
Exhibit 99.1 Medigus: Jeffs’ Brands Signs a Non-Binding Letter of Intent to Invest in a Remote Wireless Electric Charging Technology Company Jeffs’ Brands will hold a 70% interest in a new company to be incorporated that will develop laser- based charging solutions for drones and unmanned aircrafts Tel Aviv, Israel, Dec. 18, 2023 (GLOBE NEWSWIRE) - Medigus Ltd. (Nasdaq: MDGS), a technology company |
|
| December 18, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of December 2023 Commission File Number 001-37381 MEDIGUS LTD. (Translation of registrant’s name into English) 10 HaNechoshet Street, Tel-Aviv, 6971072, Israel (Address of principal executive offi |
|
| December 14, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of December 2023 Commission File Number 001-37381 MEDIGUS LTD. (Translation of registrant’s name into English) 10 HaNechoshet Street, Tel-Aviv, 6971072, Israel (Address of principal executive offi |
|
| December 14, 2023 |
Exhibit 99.1 Medigus: Jeffs’ Brands Signs a Non-Binding Letter of Intent to acquire a 70% in a Laser-based Technology Company Developing Defense Solutions Against Drone-based Visual Systems The technology solutions aim to neutralize visual systems such as cameras that are installed on drones, unmanned and manned aircrafts as well as other devices with visual systems Tel Aviv, Israel, Dec. 14, 2023 |
|
| November 22, 2023 |
Exhibit 99.1 Medigus: Charging Robotics to Receive Funding from the Israel Innovation Authority for Piloting its Wireless Charging Solution for Automated Parking System The pilot project in cooperation with Parkomot Ltd., an Israeli APS market leader, is another step towards our vision of wireless charging Tel Aviv, Israel, Nov. 22, 2023 (GLOBE NEWSWIRE) - Medigus Ltd. (Nasdaq: MDGS), a technology |
|
| November 22, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of November 2023 Commission File Number 001-37381 MEDIGUS LTD. (Translation of registrant’s name into English) 10 HaNechoshet Street Tel-Aviv, 6971072, Israel (Address of principal executive offic |
|
| November 13, 2023 |
Exhibit 99.1 Medigus: Metagramm to Develop Bubbl, its Most Advanced AI-Powered Writing and Grammar Tool Bubbl’s technology allows for innovative document re-writing and sets a new standard in the domain of writing aids Tel Aviv, Israel, Nov. 13, 2023 (GLOBE NEWSWIRE) - Medigus Ltd. (Nasdaq: MDGS), a technology company engaged in advanced medical solutions, innovative internet technologies, and ele |
|
| November 13, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of November 2023 Commission File Number 001-37381 MEDIGUS LTD. (Translation of registrant’s name into English) 10 HaNechoshet Street Tel-Aviv, 6971072, Israel (Address of principal executive offic |
|
| October 16, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of October 2023 Commission File Number 001-37381 MEDIGUS LTD. (Translation of registrant’s name into English) 10 HaNechoshet Street Tel-Aviv, 6971072, Israel (Address of principal executive office |
|
| October 16, 2023 |
Exhibit 99.1 Medigus: Revoltz Secures an Exclusive US Commercial Partnership with a Homeland Security Market Distributor The distributor committed to purchase a minimum of 500 of Revoltz’ Micro-Mobility Electric Vehicles in the coming year Tel Aviv, Israel, Oct. 16, 2023 (GLOBE NEWSWIRE) - Medigus Ltd. (Nasdaq: MDGS), a technology company engaged in electric vehicle charging solutions, advanced me |
|
| September 28, 2023 |
Exhibit 99.1 MEDIGUS LTD. INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS AS OF JUNE 30, 2023 TABLE OF CONTENTS Interim Condensed Consolidated Statements of Financial Position 2 to 3 Interim Condensed Consolidated Statements of Loss and Other Comprehensive Loss 4 Interim Condensed Consolidated Statements of Changes in Equity 5 to 6 Interim Condensed Consolidated Statements of Cash Flows 7 to 8 |
|
| September 28, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of September 2023 Commission File Number 001-37381 MEDIGUS LTD. (Translation of registrant’s name into English) 10 HaNechoshet Street Tel-Aviv, 6971072, Israel (Address of principal executive offi |
|
| September 28, 2023 |
Medigus Ltd. Operating and Financial Review as of June 30, 2023, and for the six months then ended Exhibit 99.2 Medigus Ltd. Operating and Financial Review as of June 30, 2023, and for the six months then ended The information contained in this section should be read in conjunction with (1) our unaudited interim condensed consolidated financial statements as of June 30, 2023, and for the six months then ended and related notes included in this report and (2) our audited consolidated financial s |
|
| September 28, 2023 |
Exhibit 99.1 Medigus to Acquire 60% Interest of Commercial Property in Miami The company intends to establish its presence in Miami by acquiring, improving, renovating, developing and selling commercial properties. Tel Aviv, Israel, Sept. 28, 2023 (GLOBE NEWSWIRE) - Medigus Ltd. (Nasdaq: MDGS) (“Medigus” or the “Company”), a technology company engaged in innovative internet technologies, electric |
|
| September 28, 2023 |
Medigus Announces $53.3 million in Revenues for the First Six Months of 2023 Exhibit 99.3 Medigus Announces $53.3 million in Revenues for the First Six Months of 2023 TEL AVIV, Israel, Sept. 28, 2023 (GLOBE NEWSWIRE) - Medigus Ltd. (Nasdaq: MDGS) (“Medigus”), a technology company engaged in innovative internet technologies, electric vehicle and charging solutions and advanced medical solutions, today announced financial results for the six-month periods ended June 30, 2023 |
|
| September 28, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of September 2023 Commission File Number 001-37381 MEDIGUS LTD. (Translation of registrant’s name into English) 10 HaNechoshet Street Tel-Aviv, 6971072, Israel (Address of principal executive offi |
|
| September 12, 2023 |
Medigus to Increase its Share in AI Systems to 36% Exhibit 99.1 Medigus to Increase its Share in AI Systems to 36% Tel Aviv, Israel, Sept. 12, 2023 (GLOBE NEWSWIRE) - Medigus Ltd. (Nasdaq: MDGS), a technology company engaged in advanced medical solutions, innovative internet technologies and electric vehicle and charging solutions, announced today that on September 5, 2023, AI Systems Ltd. (“AI Systems”) approved the conversion of a $1,240 thousan |
|
| September 12, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of September 2023 Commission File Number 001-37381 MEDIGUS LTD. (Translation of registrant’s name into English) 10 HaNechoshet Street Tel-Aviv, 6971072, Israel (Address of principal executive offi |
|
| September 5, 2023 |
CMNDD / Clearmind Medicine Inc / Medigus Ltd. - AMENDMENT NO. 1 TO SCHEDULE 13G Passive Investment SC 13G/A 1 ea184391-13ga1medigusclear.htm AMENDMENT NO. 1 TO SCHEDULE 13G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G/A Under the Securities Act of 1934 (Amendment No. 1) Clearmind Medicine Inc. (Name of Issuer) Common Shares, no par value (Title of Class of Securities) 1850532047 (CUSIP Number) April 6, 2023 (Date of event which requires filing of this sta |
|
| August 29, 2023 |
August 29, 2023 Via EDGAR Transmission United States Securities and Exchange Commission Division of Corporation Finance Office of Real Estate & Construction 100 F Street, N. |
|
| August 24, 2023 |
Exhibit 107 CALCULATION OF FEE TABLE FORM S-8 (Form Type) MEDIGUS LTD. (Exact Name of Registrant as Specified in its Charter) Table 1: Newly Registered Securities Plan Security Type Security Class Title Fee Calculation Rule Amount Registered(1) Proposed Maximum Offering Price Per Unit(2) Maximum Aggregate Offering Price Fee Rate Amount of Registration Fee Medigus Ltd. 2013 Share Option and Incenti |
|
| August 24, 2023 |
Registration No. 333 - As filed with the Securities and Exchange Commission on August 24, 2023 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM S-8 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Medigus Ltd. (Exact name of Registrant as specified in its charter) Israel Not Applicable (State or other jurisdiction of (IRS Employer incorporation or Organization) I |
|
| August 21, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of August 2023 Commission File Number 001-37381 MEDIGUS LTD. (Translation of registrant’s name into English) 10 HaNechoshet Street Tel-Aviv, 6971072, Israel (Address of principal executive offices |
|
| August 21, 2023 |
Exhibit 99.1 Medigus: ParaZero Signs New Development Agreement with Latin American Drone Manufacturer Black Square Tel Aviv, Israel, Aug. 21, 2023 (GLOBE NEWSWIRE) - Medigus Ltd. (Nasdaq: MDGS), a technology company engaged in electric vehicle charging solutions, advanced medical solutions, and innovative internet technologies, today announced that ParaZero Technologies Ltd. (PRZO) (“ParaZero”), a |
|
| August 18, 2023 |
As filed with the Securities and Exchange Commission on August 18, 2023 As filed with the Securities and Exchange Commission on August 18, 2023 Registration No. |
|
| August 16, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of August 2023 Commission File Number 001-37381 MEDIGUS LTD. (Translation of registrant’s name into English) 10 HaNechoshet Street Tel-Aviv, 6971072, Israel (Address of principal executive offices |
|
| August 16, 2023 |
Exhibit 99.1 Medigus: Viewbix Reports its Condensed Consolidated Financial Results for the First Half and the Second Quarter of 2023 with Revenues Totaling $48 Million for the First Half of 2023 Tel Aviv, Israel, Aug. 16, 2023 (GLOBE NEWSWIRE) - Medigus Ltd. (Nasdaq: MDGS), a technology company engaged in advanced medical solutions, innovative internet technologies and electric vehicle and chargin |
|
| August 14, 2023 |
Medigus: ParaZero Launches SafeAir M350 Pro for DJI’s New Enterprise Drone Exhibit 99.1 Medigus: ParaZero Launches SafeAir M350 Pro for DJI’s New Enterprise Drone Tel Aviv, Israel, Aug. 14, 2023 (GLOBE NEWSWIRE) - Medigus Ltd. (Nasdaq: MDGS), a technology company engaged in electric vehicle charging solutions, advanced medical solutions, and innovative internet technologies, today announced that ParaZero Technologies Ltd. (PRZO) (“ParaZero”), an aerospace company focused |
|
| August 14, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of August 2023 Commission File Number 001-37381 MEDIGUS LTD. (Translation of registrant’s name into English) 10 HaNechoshet Street Tel-Aviv, 6971072, Israel (Address of principal executive offices |
|
| August 8, 2023 |
Exhibit 99.1 Medigus: ParaZero Receives Second Order from One of the World’s Largest Automotive Manufacturers The repeat order is for a custom safety solution for a Fortune 500 automotive manufacturer’s proprietary drone program. Tel Aviv, Israel, Aug. 08, 2023 (GLOBE NEWSWIRE) - Medigus Ltd. (Nasdaq: MDGS), a technology company engaged in electric vehicle charging solutions, advanced medical solu |
|
| August 8, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of August 2023 Commission File Number 001-37381 MEDIGUS LTD. (Translation of registrant’s name into English) 10 HaNechoshet Street Tel-Aviv, 6971072, Israel (Address of principal executive offices |
|
| August 8, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of August 2023 Commission File Number 001-37381 MEDIGUS LTD. (Translation of registrant’s name into English) 10 HaNechoshet Street Tel-Aviv, 6971072, Israel (Address of principal executive offices |
|
| August 4, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of August 2023 Commission File Number 001-37381 MEDIGUS LTD. (Translation of registrant’s name into English) 10 HaNechoshet Street Tel-Aviv, 6971072, Israel (Address of principal executive offices |
|
| August 4, 2023 |
EX-99.1 2 ea182889ex99-1medigus.htm PRESS RELEASE DATED AUGUST 4, 2023 Exhibit 99.1 Medigus: Charging Robotics to Install its Wireless EV Charging System with a Leading Automatic Carpark Provider Upon successful completion of this evaluation, the parties will enter into a definitive agreement for purchase of Wireless EV Charging Systems. Tel Aviv, Israel, Aug. 04, 2023 (GLOBE NEWSWIRE) - Medigus L |
|
| July 27, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of July 2023 Commission File Number 001-37381 MEDIGUS LTD. (Translation of registrant’s name into English) 10 HaNechoshet Street Tel-Aviv, 6971072, Israel (Address of principal executive offices) |
|
| July 27, 2023 |
Exhibit 99.1 Medigus’ Drones Safety Company, ParaZero (PRZO), to Commence Trading on Nasdaq Today ParaZero Announces Initial Public Offering (IPO) Pricing of $7.8 million Tel Aviv, Israel, July 27, 2023 (GLOBE NEWSWIRE) - Medigus Ltd. (Nasdaq: MDGS), a technology company engaged in advanced medical solutions, innovative internet technologies, and electric vehicle and charging solutions, announced |
|
| July 11, 2023 |
July 11, 2023 United State Securities and Exchange Commission Division of Corporation Finance Office of Technology 100 F Street, N. |
|
| July 7, 2023 |
Exhibit 99.1 Medigus: Jeffs’ Brands to Acquire 50.01% Interest in an AI marketing Business to Enhance Its Machine Learning Capabilities Jeffs’ Brands has entered into a non-binding letter of intent for, among others, the integration of the AI-based tool developed by B24Chat which will strengthen Jeffs’ Brands’ in-house marketing system and upgrade its marketing and services performance Tel Aviv, I |
|
| July 7, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of July 2023 Commission File Number 001-37381 MEDIGUS LTD. (Translation of registrant’s name into English) 10 HaNechoshet Street Tel-Aviv, 6971072, Israel (Address of principal executive offices) |
|
| June 30, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of June 2023 Commission File Number 001-37381 MEDIGUS LTD. (Translation of registrant’s name into English) 10 HaNechoshet Street Tel-Aviv, 6971072, Israel (Address of principal executive offices) |
|
| June 30, 2023 |
HaNechoshet 10, Tel-Aviv, 6971072 Exhibit 99.1 HaNechoshet 10, Tel-Aviv, 6971072 Israel June 30, 2023 Dear Shareholder: You are cordially invited to attend the annual general meeting (the “Meeting”) of the shareholders of Medigus Ltd. (the “Company”), to be held on Monday, August 7, 2023, beginning at 5:00 PM, Israel time (10:00 AM Eastern time), at the offices of Meitar | Law Offices, 16 Abba Hillel Silver Rd. Ramat Gan, Israel 5 |
|
| June 30, 2023 |
Exhibit 99.2 |
|
| June 6, 2023 |
Medigus Sells its Entire Stake in ScoutCam for Approximately $6 Million in Cash Exhibit 99.1 Medigus Sells its Entire Stake in ScoutCam for Approximately $6 Million in Cash Tel Aviv, Israel, June 06, 2023 (GLOBE NEWSWIRE) - Medigus Ltd. (Nasdaq: MDGS) (“Medigus”), a technology company engaged in advanced medical solutions, innovative internet technologies and electric vehicle (“EV”) and charging solutions, today announced that it has sold its entire stake in ScoutCam Inc. (OT |
|
| June 6, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of June 2023 Commission File Number 001-37381 MEDIGUS LTD. (Translation of registrant’s name into English) 10 HaNechoshet Street Tel-Aviv, 6971072, Israel (Address of principal executive offices) |
|
| May 16, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of May 2023 Commission File Number 001-37381 MEDIGUS LTD. (Translation of registrant’s name into English) 10 HaNechoshet Street Tel-Aviv, 6971072, Israel (Address of principal executive offices) I |
|
| May 16, 2023 |
EX-1.2 2 ea178653ex1-2medigus.htm AT-THE-MARKET ISSUANCE SALES AGREEMENT, DATED MAY 16, 2023 BY AND BETWEEN THE MEDIGUS LTD. AND AEGIS CAPITAL CORP Exhibit 1.2 Medigus Ltd. American Depositary Shares, Each Representing Fifteen (15) Ordinary Shares At-The-Market Issuance Sales Agreement May 16, 2023 Aegis Capital Corp. 1345 Avenue of the Americas, 27th Floor New York, New York 10015 Ladies and Gent |
|
| May 16, 2023 |
Exhibit 99.1 Medigus: Viewbix Reports Revenues of $20.9 Million in The First Quarter of 2023 Viewbix, together with its subsidiaries, reached EBITDA of $658 thousand Tel Aviv, Israel, May 16, 2023 (GLOBE NEWSWIRE) - Medigus Ltd. (Nasdaq: MDGS), a technology company engaged in advanced medical solutions, innovative internet technologies and electric vehicle and charging solutions, announced today t |
|
| May 16, 2023 |
Exhibit 107 CALCULATION OF FEE TABLE FORM F-3 (Form Type) MEDIGUS LTD. (Exact Name of Registrant as Specified in its Charter) Table 1: Newly Registered Securities Security Type Security Class Title Fee Calculation or Carry Forward Rule Amount Registered Proposed Maximum Offering Price Per Unit Maximum Aggregate Offering Price Fee Rate Amount of Registration Fee Carry Forward Form Type Carry Forwar |
|
| May 16, 2023 |
As filed with the Securities and Exchange Commission on May 16, 2023 As filed with the Securities and Exchange Commission on May 16, 2023 Registration No. |
|
| May 4, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of May 2023 Commission File Number 001-37381 MEDIGUS LTD. (Translation of registrant’s name into English) 10 HaNechoshet Street Tel-Aviv, 6971072, Israel (Address of principal executive offices) I |
|
| May 4, 2023 |
Exhibit 99.1 Medigus Announces Record 2022 Financial Results Record Revenues of approx. $92 million, up over 800% Y-o-Y TEL AVIV, Israel, May 4, 2022 (GLOBE NEWSWIRE) - Medigus Ltd. (Nasdaq: MDGS) (“Medigus”), a technology company engaged in advanced medical solutions, innovative internet technologies and electric vehicle and charging solutions, today announced financial results and the filing of |
|
| May 3, 2023 |
Exhibit 13.2 CERTIFICATION PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (SUBSECTIONS (a) AND (b) OF SECTION 1350, CHAPTER 63 OF TITLE 18, UNITED STATES CODE) Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (Subsections (a) and (b) of Section 1350, Chapter 63 of Title 18, United States Code), the undersigned officer of Medigus Ltd., a company organized under the laws of the S |
|
| May 3, 2023 |
AMENDMENT TO THE LOAN AGREEMENT EX-4.7 5 f20f2022ex4-7medigusltd.htm AMENDMENT TO THE LOAN AGREEMENT BY AND BETWEEN THE COMPANY AND GIX INTERNET LTD. DATED AUGUST 25, 2022, AND EFFECTIVE AS OF JULY 1, 2022 Exhibit 4.7 AMENDMENT TO THE LOAN AGREEMENT This Amendment (“Amendment”) to the Loan Agreement (as defined below) is entered into as of August 25, 2022 with the effective date of July 1 2022 (“Amendment Effective Date”) by and |
|
| May 3, 2023 |
Exhibit 12.1 CERTIFICATION I, Liron Carmel, certify that: 1. I have reviewed this annual report on Form 20-F of Medigus Ltd.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the per |
|
| May 3, 2023 |
Exhibit 13.1 CERTIFICATION PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (SUBSECTIONS (a) AND (b) OF SECTION 1350, CHAPTER 63 OF TITLE 18, UNITED STATES CODE) Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (Subsections (a) and (b) of Section 1350, Chapter 63 of Title 18, United States Code), the undersigned officer of Medigus Ltd., a company organized under the laws of the S |
|
| May 3, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 20-F ☐ REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE FISCAL YEAR ENDED DECEMBER 31, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT O |
|
| May 3, 2023 |
Exhibit 1.1 THE COMPANIES LAW, 1999 A LIMITED LIABILITY COMPANY - AMENDED AND RESTATED ARTICLES OF ASSOCIATION OF MEDIGUS LTD. As Adopted on June 17, 2022 Preliminary 1. Definitions; Interpretation. (a) In these Articles, the following terms (whether or not capitalized) shall bear the meanings set forth opposite them, respectively, unless the subject or context requires otherwise. “Affiliate” with |
|
| May 3, 2023 |
Exhibit 12.2 CERTIFICATION I, Tali Dinar, certify that: 1. I have reviewed this annual report on Form 20-F of Medigus Ltd.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the perio |
|
| May 3, 2023 |
Exhibit 2.3 Description of Securities The following description of Medigus Ltd.’s (the “Company”) share capital, provisions of its amended and restated articles of association as may be amended and restated from time to time, and Israeli law are summaries and do not purport to be complete, and is qualified in its entirety by reference to, the provisions of our amended and restated articles of asso |
|
| May 3, 2023 |
Exhibit 4.6 LOAN AGREEMENT This Loan Agreement (this “Loan Agreement”) is made and entered into as of the 12 day of October 2021 (the “Effective Date”) between Medigus Ltd., a company organized under the State of Israel, with principal offices at Omer Industrial Park, No.7A, P.O. Box 3030, Omer 8496500, Israel (the “Lender”), and Gix Internet Ltd. (f/k/a Algomizer Ltd.), a company organized under |
|
| May 3, 2023 |
Exhibit 4.9 SECURITIES EXCHANGE AGREEMENT THIS SECURITIES EXCHANGE AGREEMENT (the “Agreement”) is entered into as of March 28, 2023 (the “Effective Date”), by and between Medigus Ltd., an Israeli Corporation (“Medigus”), the additional shareholders of Charging Robotics Ltd. listed on Schedule 1 attached hereto (together with Medigus, the “CR Shareholders”), and Fuel Doctor Holdings, Inc., a public |
|
| May 3, 2023 |
Exhibit 4.8 Share Purchase Agreement Among ParaZero Technologies Ltd. (the “Company”) and Delta Drone International Ltd (ACN 618 678 701) (the “Seller”) and L.I.A Pure Capital Ltd. and additional entities on its behalf as listed in Exhibit A (each an “Acquiror” and collectively, the “acquirers”) Dated January 28, 2022 TABLE OF CONTENTS ARTICLE 1 Certain Definitions 1 ARTICLE 2 The Share Purchase 9 |
|
| May 3, 2023 |
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM EX-15.1 13 f20f2022ex15-1medigusltd.htm CONSENT OF BRIGHTMAN ALMAGOR ZOHAR & CO., CERTIFIED PUBLIC ACCOUNTANT (ISR.), A FIRM IN THE DELOITTE GLOBAL NETWORK, INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR MEDIGUS LTD Exhibit 15.1 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM We hereby consent to the incorporation by reference in the Registration Statements on Form F-3 (Nos. 333-238162 |
|
| April 28, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 12b-25 Commission File Number: 001-37381 NOTIFICATION OF LATE FILING (Check One): ☐ Form 10-K ☒ Form 20-F ☐ Form 11-K ☐ Form 10-Q ☐ Form N-SAR ☐ Form N-CSR For Period Ended: December 31, 2022 ☐ Transition Report on Form 10-K ☐ Transition Report on Form 20-F ☐ Transition Report on Form 11-K ☐ Transition Report on Form 10-Q |
|
| April 27, 2023 |
Exhibit 99.1 Medigus: Charging Robotics’ AI Based Solution Ranked Among Top Outstanding Techpreneurs at the 14th Innovation World Cup The competition is in partnership with Industry giants like STMicroelectronics, EBV Elektronik, Würth Elektronik, VARTA Microbattery Tel Aviv, Israel, April 27, 2023 (GLOBE NEWSWIRE) - Medigus Ltd. (Nasdaq: MDGS), a technology company engaged in electric vehicle cha |
|
| April 27, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of April 2023 Commission File Number 001-37381 MEDIGUS LTD. (Translation of registrant’s name into English) 10 HaNechoshet Street Tel-Aviv, 6971072, Israel (Address of principal executive offices) |
|
| April 18, 2023 |
EX-99.1 2 ea177102ex99-1medigus.htm PRESS RELEASE DATED APRIL 18, 2023 Exhibit 99.1 Medigus’s Subsidiary for EV Wireless Charging Merged with a Public Company in the US and Commenced Trading on the OTC Market Medigus holds 60% in the public company and has an option to increase its holdings up to 71% Tel Aviv, Israel, April 18, 2023 (GLOBE NEWSWIRE) – Medigus Ltd. (Nasdaq: MDGS), a technology comp |
|
| April 18, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of April 2023 Commission File Number 001-37381 MEDIGUS LTD. (Translation of registrant’s name into English) 10 HaNechoshet Street Tel-Aviv, 6971072, Israel (Address of principal executive offices) |
|
| April 13, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of April 2023 Commission File Number 001-37381 MEDIGUS LTD. (Translation of registrant’s name into English) 10 HaNechoshet Street Tel-Aviv, 6971072, Israel (Address of principal executive offices) |
|
| April 13, 2023 |
Exhibit 99.1 Medigus Acquires 19.9% of Innovative AI and Natural Language Processing Communication Based Software Company Metagramm Software Ltd. has developed an advanced grammar engine, which serves as the core of its online writing solution and a fully integrated writing solution for Windows desktop Tel Aviv, Israel, April 13, 2023 (GLOBE NEWSWIRE) - Medigus Ltd. (Nasdaq: MDGS), a technology co |
|
| March 27, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of March 2023 Commission File Number 001-37381 MEDIGUS LTD. (Translation of registrant’s name into English) 10 HaNechoshet Street Tel-Aviv, 6971072, Israel (Address of principal executive offices) |
|
| March 27, 2023 |
Exhibit 99.1 Medigus: Viewbix Reports its Financial Results for 2022 with a 114% Growth in Revenues Totaling $97 Million Viewbix is a subsidiary of Gix Internet whose results are consolidated with Medigus’ financial statements Tel Aviv, Israel, March 27, 2023 (GLOBE NEWSWIRE) - Medigus Ltd. (Nasdaq: MDGS), a technology company engaged in advanced medical solutions, innovative internet technologies |
|
| March 21, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of March 2023 Commission File Number 001-37381 MEDIGUS LTD. (Translation of registrant’s name into English) 10 HaNechoshet Street Tel-Aviv, 6971072, Israel (Address of principal executive offices) |
|
| March 21, 2023 |
Medigus: ScoutCam Closes $14 Million Private Placement Exhibit 99.1 Medigus: ScoutCam Closes $14 Million Private Placement Tel Aviv, Israel, March 21, 2023 (GLOBE NEWSWIRE) - Medigus Ltd. (Nasdaq: MDGS) (“Medigus”), a technology company engaged in advanced medical solutions, innovative internet technologies and electric vehicle (“EV”) and charging solutions, today announced that ScoutCam Inc. (OTCQB: SCTC)(“ScoutCam”, 27.01% owned by Medigus prior to |
|
| February 23, 2023 |
Exhibit 99.1 Medigus: Jeffs’ Brands Entered Into Non-Binding Letter of Intent with SuperBuzz for Developing AI-Based Software for Amazon’s Advertisement Platform Tel Aviv, Israel, Feb. 23, 2023 (GLOBE NEWSWIRE) - Medigus Ltd. (Nasdaq: MDGS) (“Medigus”), a technology company engaged in advanced medical solutions, innovative internet technologies and electric vehicle (“EV”) and charging solutions, a |
|
| February 23, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of February 2023 Commission File Number 001-37381 MEDIGUS LTD. (Translation of registrant’s name into English) 10 HaNechoshet Street, 6971072, Israel (Address of principal executive offices) Indic |
|
| February 10, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of February 2023 Commission File Number 001-37381 MEDIGUS LTD. (Translation of registrant’s name into English) 10 HaNechoshet Street, 6971072, Israel (Address of principal executive offices) Indic |
|
| February 9, 2023 |
CMNDD / Clearmind Medicine Inc / Medigus Ltd. - SCHEDULE 13G Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Act of 1934 Clearmind Medicine Inc. (Name of Issuer) Common Shares, no par value (Title of Class of Securities) 1850532047 (CUSIP Number) December 31, 2022 (Date of event which requires filing of this statement) Check the appropriate box to designate the rule pursuant to which this Schedule is |
|
| February 8, 2023 |
6-K 1 ea172960-6kmedigus.htm REPORT OF FOREIGN PRIVATE ISSUER UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of February 2023 Commission File Number 001-37381 MEDIGUS LTD. (Translation of registrant’s name into English) 10 HaNechoshet Street, |
|
| February 8, 2023 |
EX-99.1 2 ea172960ex99-1medigus.htm PRESS RELEASE DATED FEBRUARY 8, 2023 Exhibit 99.1 Medigus: Elbit Systems and ScoutCam Complete Major Development Stage in Real Time Video Monitoring Program Tel Aviv, Israel, Feb. 08, 2023 (GLOBE NEWSWIRE) - Medigus Ltd. (Nasdaq: MDGS) (“Medigus”), a technology company engaged in advanced medical solutions, innovative internet technologies and electric vehicle ( |
|
| February 7, 2023 |
EX-99.1 2 ea172795ex99-1medigusltd.htm PRESS RELEASE DATED FEBRUARY 7, 2023 Exhibit 99.1 Medigus: Charging Robotics was Nominated for and Submitted its AI based Solution to the 14th Innovation World Cup The competition is in partnership with Industry giants like: STMicroelectronics, EBV Elektronik, Würth Elektronik, VARTA Microbattery Tel Aviv, Israel, Feb. 07, 2023 (GLOBE NEWSWIRE) - Medigus Ltd. |
|
| February 7, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of February 2023 Commission File Number 001-37381 MEDIGUS LTD. (Translation of registrant’s name into English) 10 HaNechoshet Street, 6971072, Israel (Address of principal executive offices) Indic |
|
| January 30, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of January 2023 Commission File Number 001-37381 MEDIGUS LTD. (Translation of registrant’s name into English) 3 HaNechoshet Street, Building B, 6971068, Israel (Address of principal executive offi |
|
| January 30, 2023 |
Exhibit 99.1 Medigus: ScoutCam Announces $1.45 Million Order to Provide Miniature Camera Solution to Leading Fortune 500 Multinational Healthcare Corporation Tel Aviv, Israel, Jan. 30, 2023 (GLOBE NEWSWIRE) - Medigus Ltd. (Nasdaq: MDGS) (“Medigus”), a technology company engaged in advanced medical solutions, innovative internet technologies and electric vehicle (“EV”) and charging solutions, today |
|
| January 30, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of January 2023 Commission File Number 001-37381 MEDIGUS LTD. (Translation of registrant’s name into English) 3 HaNechoshet Street, Building B, 6971068, Israel (Address of principal executive offi |
|
| January 26, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of January 2023 Commission File Number 001-37381 MEDIGUS LTD. (Translation of registrant’s name into English) 3 HaNechoshet Street, Building B, 6971068, Israel (Address of principal executive offi |
|
| January 26, 2023 |
Medigus: Gix Media Increases Holdings in Cortex Media Group to 80% of its Share Capital EX-99.1 2 ea172245ex99-1medigusltd.htm PRESS RELEASE DATED JANUARY 26, 2023 Exhibit 99.1 Medigus: Gix Media Increases Holdings in Cortex Media Group to 80% of its Share Capital Tel Aviv, Israel, Jan. 26, 2023 (GLOBE NEWSWIRE) - Medigus Ltd. (Nasdaq: MDGS), a technology company engaged in advanced medical solutions, innovative internet technologies and electric vehicle and charging solutions, today |
|
| January 9, 2023 |
6-K 1 ea171410-6kmedigusltd.htm REPORT OF FOREIGN PRIVATE ISSUER UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of January 2023 Commission File Number 001-37381 MEDIGUS LTD. (Translation of registrant’s name into English) 3 HaNechoshet Street, |
|
| January 9, 2023 |
Exhibit 99.1 Medigus: Eventer Technologies Signed a Definitive Agreement for Reverse Merger to Become a Public Company Eventer will merge with a Tel-Aviv Stock Exchange listed company following which Eventer shareholdres will hold 74.99% of the merged company Tel Aviv, Israel, Jan. 09, 2023 (GLOBE NEWSWIRE) - Medigus Ltd. (Nasdaq: MDGS), a technology company engaged in advanced medical solutions, |
|
| December 8, 2022 |
EX-99.1 2 ea169655ex99-1medigusltd.htm PRESS RELEASE DATED DECEMBER 5, 2022 Exhibit 99.1 Medigus Announces Details of its $1.6 Million Cash Capital Distribution The Cash Capital Represents 14.38% of the ADS Closing Price on December 7, 2022 Tel Aviv, Israel, Dec. 08, 2022 (GLOBE NEWSWIRE) - Medigus Ltd. (Nasdaq: MDGS), a technology company engaged in advanced medical solutions, innovative internet |
|
| December 8, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of December 2022 Commission File Number 001-37381 MEDIGUS LTD. (Translation of registrant’s name into English) 3 HaNechoshet Street, Building B, 6971068, Israel (Address of principal executive off |
|
| November 30, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of November 2022 Commission File Number 001-37381 MEDIGUS LTD. (Translation of registrant?s name into English) 3 HaNechoshet Street, Building B, 6971068, Israel (Address of principal executive off |
|
| November 30, 2022 |
Medigus Regains Compliance with Nasdaq Minimum Closing Bid Price Rule Exhibit 99.1 Medigus Regains Compliance with Nasdaq Minimum Closing Bid Price Rule Tel Aviv, Israel, Nov. 30, 2022 (GLOBE NEWSWIRE) - Medigus Ltd. (Nasdaq: MDGS), a technology company engaged in advanced medical solutions, innovative internet technologies, and electric vehicle and charging solutions, today reported the receipt of a formal notification from The Nasdaq Stock Market LLC (?Nasdaq?) th |
|
| November 25, 2022 |
EX-99.1 2 ea169289ex99-1medigus.htm PRESS RELEASE DATED NOVEMBER 25, 2022 Exhibit 99.1 Medigus: Charging Robotics to Release a Beta Version of its User Interface by the End of the Year The app will be released as part of the collaboration between Charging Robotics and Make My Day – a company specializing in electric vehicle fleet management. Tel Aviv, Israel, Nov. 25, 2022 (GLOBE NEWSWIRE) - Medig |
|
| November 25, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of November 2022 Commission File Number 001-37381 MEDIGUS LTD. (Translation of registrant?s name into English) 3 HaNechoshet Street, Building B, 6971068, Israel (Address of principal executive off |
|
| November 23, 2022 |
EX-99.1 2 ea169200ex99-1medigusltd.htm PRESS RELEASE DATED NOVEMBER 23, 2022 Exhibit 99.1 Medigus: Viewbix Reports Record Revenues of $66 million in the First Nine Months of 2022 Representing Increase of 176% Viewbix is a subsidary of Gix Internet whose results consolidated with Medigus’ financial Tel Aviv, Israel, Nov. 23, 2022 (GLOBE NEWSWIRE) - Medigus Ltd. (Nasdaq: MDGS), a technology company |
|
| November 23, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of November 2022 Commission File Number 001-37381 MEDIGUS LTD. (Translation of registrant’s name into English) 3 HaNechoshet Street, Building B, 6971068, Israel (Address of principal executive off |
|
| November 18, 2022 |
6-K 1 ea168926-6kmedigusltd.htm REPORT OF FOREIGN PRIVATE ISSUER UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of November 2022 Commission File Number 001-37381 MEDIGUS LTD. (Translation of registrant’s name into English) 3 HaNechoshet Street |
|
| November 18, 2022 |
EX-99.1 2 ea168926ex99-1medigusltd.htm PRESS RELEASE DATED NOVEMBER 18, 2022 Exhibit 99.1 Medigus Announces Cash Capital Distribution of $1.6 Million The Company will provide an update regarding the distribution date Tel Aviv, Israel, Nov. 18, 2022 (GLOBE NEWSWIRE) - Medigus Ltd. (Nasdaq: MDGS), a technology company engaged in advanced medical solutions, innovative internet technologies, and elect |
|
| November 17, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of November 2022 Commission File Number 001-37381 MEDIGUS LTD. (Translation of registrant?s name into English) 3 HaNechoshet Street, Building B, 6971068, Israel (Address of principal executive off |
|
| November 17, 2022 |
EX-99.1 2 ea168892ex99-1medigusltd.htm PRESS RELEASE DATED NOVEMBER 17, 2022 Exhibit 99.1 Medigus: An International Aerospace Company has Purchased Dozens of ParaZero’s SafeAir Safety Systems The purchase order amounts to approximately $241,000 USD Tel Aviv, Israel, November 17, 2022 (GLOBE NEWSWIRE) - Medigus Ltd. (Nasdaq: MDGS), a technology company engaged in advanced medical solutions, innovat |
|
| November 16, 2022 |
Exhibit 99.1 Medigus: Eventer Technologies Signed a Letter of Intent for Spin-Off and an approx. $13 million Reverse Merger The letter of intent was signed with a Tel-Aviv Stock Exchange listed company to hold 74.99% of the merged company Tel Aviv, Israel, Nov. 16, 2022 (GLOBE NEWSWIRE) - Medigus Ltd. (Nasdaq: MDGS), a technology company engaged in advanced medical solutions, innovative internet t |
|
| November 16, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of November 2022 Commission File Number 001-37381 MEDIGUS LTD. (Translation of registrant’s name into English) 3 HaNechoshet Street, Building B, 6971068, Israel (Address of principal executive off |
|
| November 15, 2022 |
EX-99.1 2 ea168709ex99-1medigusltd.htm PRESS RELEASE DATED NOVEMBER 15, 2022 Exhibit 99.1 Medigus: Eventer Generated Record Revenues for the First Nine Months of 2022 Exceeding Full-Year 2021 Revenues Revenues for the first nine months of 2022 were approx. $1.99 million Tel Aviv, Israel, Nov. 15, 2022 (GLOBE NEWSWIRE) - Medigus Ltd. (Nasdaq: MDGS), a technology company engaged in advanced medical |
|
| November 15, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of November 2022 Commission File Number 001-37381 MEDIGUS LTD. (Translation of registrant’s name into English) 3 HaNechoshet Street, Building B, 6971068, Israel (Address of principal executive off |
|
| November 14, 2022 |
Exhibit 99.1 Medigus: Charging Robotics Filed Patent Application for a Unique Wireless Charging Method for Automated Car Parks Charging Robotics? innovation addresses the inability to charge electric vehicles in existing unmanned car parks Tel Aviv, Israel, Nov. 14, 2022 (GLOBE NEWSWIRE) - Medigus Ltd. (Nasdaq: MDGS), a technology company engaged in advanced medical solutions, innovative internet |
|
| November 14, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of November 2022 Commission File Number 001-37381 MEDIGUS LTD. (Translation of registrant’s name into English) 3 HaNechoshet Street, Building B, 6971068, Israel (Address of principal executive off |
|
| November 14, 2022 |
EX-99.1 2 ea168480ex99-1medigus.htm PRESS RELEASE DATED NOVEMBER 11, 2022 Exhibit 99.1 Medigus: Jeffs’ Brands Reinforces its Brands for the Holiday Season with Potential High Profitability Products Using its advanced technology, Jeffs’ Brands evaluated new lucrative products and now offers them in its stores Tel Aviv, Israel, Nov. 11, 2022 (GLOBE NEWSWIRE) - Medigus Ltd. (Nasdaq: MDGS), a technolo |
|
| November 14, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of November 2022 Commission File Number 001-37381 MEDIGUS LTD. (Translation of registrant?s name into English) 3 HaNechoshet Street, Building B, 6971068, Israel (Address of principal executive off |
|
| November 8, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of November 2022 Commission File Number 001-37381 MEDIGUS LTD. (Translation of registrant’s name into English) 3 HaNechoshet Street, Building B, 6971068, Israel (Address of principal executive off |
|
| November 8, 2022 |
Medigus: Jeffs' Brands to Expand Sales Beyond Amazon.com into New Leading E-commerce Platforms EX-99.1 2 ea168212ex99-1medigus.htm PRESS RELEASE DATED NOVEMBER 8, 2022 Exhibit 99.1 Medigus: Jeffs' Brands to Expand Sales Beyond Amazon.com into New Leading E-commerce Platforms Tel Aviv, Israel – November 8, 2022 (GLOBE NEWSWIRE) Medigus Ltd. (Nasdaq: MDGS), a technology company engaged in advanced medical solutions, innovative internet technologies, and electric vehicle and charging solutions |
|
| November 8, 2022 |
Rule 424(b)(3) File No. 333-203937 Note: This revised form of American Depositary Receipt is being filed to reflect that the ratio of Shares per American Depositary Share has changed from one share to fifteen shares, effective November 14, 2022. EXHIBIT A AMERICAN DEPOSITARY SHARES (Each American Depositary Share represents fifteen (15) deposited Shares) THE BANK OF NEW YORK MELLON AMERICAN DEPOSI |
|
| October 31, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of October 2022 Commission File Number 001-37381 MEDIGUS LTD. (Translation of registrant’s name into English) 3 HaNechoshet Street, Building B, 6971068, Israel (Address of principal executive offi |
|
| October 31, 2022 |
Medigus Announces Plan to Implement ADS Ratio Change Exhibit 99.1 Medigus Announces Plan to Implement ADS Ratio Change Tel Aviv, Israel, Oct. 31, 2022 (GLOBE NEWSWIRE) - Medigus Ltd. (Nasdaq: MDGS) (“Medigus”), a technology company engaged in advanced medical solutions, innovative internet technologies and electric vehicle (“EV”) and charging solutions, announced today that it plans to effect 1:15 ratio change of the Company’s American Depositary Re |
|
| October 21, 2022 |
EX-99.1 2 ea167373ex99-1medigus.htm MEDIGUS CORPORATE PRESENTATION - H1 2022 Exhibit 99.1 NASDAQ: MDGS Corporate Presentation H ϭ 2022 Forward Looking Statements This presentation may contain statements about Medigus Ltd . and its subsidiaries (the “ Company ” ) that are “ Forward - Looking Statements, ” which are based upon the current estimates, assumptions and expectations of the Company ’ s ma |
|
| October 21, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of October 2022 Commission File Number 001-37381 MEDIGUS LTD. (Translation of registrant?s name into English) 3 HaNechoshet Street, building B, 6971068, Tel Aviv, Israel (Address of principal exec |
|
| October 19, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of October 2022 Commission File Number 001-37381 MEDIGUS LTD. (Translation of registrant’s name into English) 3 HaNechoshet Street, Building B, 6971068, Israel (Address of principal executive offi |
|
| October 19, 2022 |
Medigus: ScoutCam Announces Appointment of Yehu Ofer as Chief Executive Officer Exhibit 99.1 Medigus: ScoutCam Announces Appointment of Yehu Ofer as Chief Executive Officer Tel Aviv, Israel, Oct. 19, 2022 (GLOBE NEWSWIRE) - Medigus Ltd. (Nasdaq: MDGS) (“Medigus”), a technology company engaged in advanced medical solutions, innovative internet technologies and electric vehicle (“EV”) and charging solutions, announced today that ScoutCam Inc. (OTCQB: SCTC) (“ScoutCam”, owned 27 |
|
| September 23, 2022 |
Medigus Ltd. Operating and Financial Review as of June 30, 2022, and for the six months then ended Exhibit 99.2 Medigus Ltd. Operating and Financial Review as of June 30, 2022, and for the six months then ended The information contained in this section should be read in conjunction with (1) our unaudited interim condensed consolidated financial statements as of June 30, 2022, and for the six months then ended and related notes included in this report and (2) our audited consolidated financial s |
|
| September 23, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of September 2022 Commission File Number 001-37381 MEDIGUS LTD. (Translation of registrant?s name into English) 3 HaNechoshet Street, Building B, 6971068, Israel (Address of principal executive of |
|
| September 23, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of September 2022 Commission File Number 001-37381 MEDIGUS LTD. (Translation of registrant?s name into English) 3 HaNechoshet Street, building B, 6971068, Tel Aviv, Israel (Address of principal ex |
|
| September 23, 2022 |
Exhibit 99.1 MEDIGUS LTD. INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS AS OF JUNE 30, 2022 MEDIGUS LTD. TABLE OF CONTENTS Page Interim Condensed Consolidated Financial Statements ? in US Dollars (USD) in thousands: Interim Condensed Consolidated Balance Sheets 2-3 Interim Condensed Consolidated Statements of Loss and Other Comprehensive Loss 4 Interim Condensed Consolidated Statements of Ch |
|
| September 23, 2022 |
Exhibit 99.1 Medigus Announces Record 2022 First Half Financial Results Record Revenues of $34.95 million, up over 1,300% Y-o-Y Tel Aviv, Israel? September 23, 2022 ? Medigus Ltd. (Nasdaq: MDGS) (?Medigus?), a technology company engaged in advanced medical solutions, innovative internet technologies and electric vehicle and charging solutions, today reported financial results for the six months en |
|
| September 13, 2022 |
SC 13D 1 ea165713-13dmedigusjeffs.htm SCHEDULE 13D UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULE 13d-1(a) AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13d-2(a) JEFFS’ BRANDS LTD (Name of Issuer) ORDINARY SHARES, NO PAR VALUE PER SHARE M61472102 (Title of |
|
| September 12, 2022 |
Medigus: Polyrizon Submitted an International Patent Application for its Platform Technologies EX-99.1 2 ea165649ex99-1medigusltd.htm PRESS RELEASE DATED SEPTEMBER 12, 2022 Exhibit 99.1 Medigus: Polyrizon Submitted an International Patent Application for its Platform Technologies Tel Aviv, Israel, Sept. 12, 2022 (GLOBE NEWSWIRE) - Medigus Ltd. (Nasdaq: MDGS), a technology company engaged in advanced medical solutions, innovative internet technologies and electric vehicle (“EV”) and charging |
|
| September 12, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of September 2022 Commission File Number 001-37381 MEDIGUS LTD. (Translation of registrant?s name into English) 3 HaNechoshet Street, Building B, 6971068, Israel (Address of principal executive of |
|
| September 8, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of September 2022 Commission File Number 001-37381 MEDIGUS LTD. (Translation of registrant?s name into English) 3 HaNechoshet Street, Building B, 6971068, Israel (Address of principal executive of |
|
| September 8, 2022 |
Medigus Board Files a Motion to Approve an Up to $1.6 Million Dividend Distribution Exhibit 99.1 Medigus Board Files a Motion to Approve an Up to $1.6 Million Dividend Distribution Tel Aviv, Israel ? September 8, 2022 (GLOBE NEWSWIRE) Medigus Ltd. (Nasdaq: MDGS), a technology company engaged in advanced medical solutions, innovative internet technologies, and electric vehicle and charging solutions, announced today that the Company filed a motion with the Tel Aviv District Court |
|
| September 6, 2022 |
EX-99.1 2 ea165381ex99-1medigusltd.htm PRESS RELEASE DATED SEPTEMBER 6, 2022 Exhibit 99.1 Medigus: Eventer Achieved Record Revenues increase of 211% Year-Over-Year to Approximately $1.4 Million in The First Half of 2022 Eventer’s turnover from tickets sales for the first half of 2022 amounted to approx. $35 million an increase of approx. 307% compared to the first half of 2021 Tel Aviv, Israel – S |
|
| September 6, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of September 2022 Commission File Number 001-37381 MEDIGUS LTD. (Translation of registrant?s name into English) 3 HaNechoshet Street, building B, 6971068, Tel Aviv, Israel (Address of principal ex |
|
| September 1, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of September 2022 Commission File Number 001-37381 MEDIGUS LTD. (Translation of registrant?s name into English) 3 HaNechoshet Street, building B, 6971068, Tel Aviv, Israel (Address of principal ex |
|
| September 1, 2022 |
Exhibit 99.1 Medigus: Jeffs? Brands Ltd. Announces Closing of $15.5 Million Initial Public Offering As a result of the closing, Medigus now owns 35.27% of Jeffs' Brands Tel Aviv, Israel ? September 1, 2022 (GLOBE NEWSWIRE) Medigus Ltd. (Nasdaq: MDGS), a technology company engaged in advanced medical solutions, innovative internet technologies, and electric vehicle and charging solutions, announced |
|
| August 30, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of August 2022 Commission File Number 001-37381 MEDIGUS LTD. (Translation of registrant?s name into English) 3 HaNechoshet Street, building B, 6971068, Tel Aviv, Israel (Address of principal execu |
|
| August 30, 2022 |
Exhibit 99.1 Medigus: Gix Internet Reports Revenues Increase of 166% Year-over-Year to Approximately $43.4 Million in the First Half of 2022 Medigus? financials results for the first half of 2022 will include, for the first time, the consolidation of Gix Internet?s financials Tel Aviv, Israel ? August 30, 2022 (GLOBE NEWSWIRE) - Medigus Ltd. (Nasdaq: MDGS), a technology company engaged in advanced |
|
| August 29, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of August 2022 Commission File Number 001-37381 MEDIGUS LTD. (Translation of registrant?s name into English) 3 HaNechoshet Street, building B, 6971068, Tel Aviv, Israel (Address of principal execu |
|
| August 29, 2022 |
Medigus: Jeffs’ Brands Ltd. Announces Pricing of $15.5 Million Initial Public Offering EX-99.1 2 ea165084ex99-1medigus.htm PRESS RELEASE DATED AUGUST 29, 2022 Exhibit 99.1 Medigus: Jeffs’ Brands Ltd. Announces Pricing of $15.5 Million Initial Public Offering Tel Aviv, Israel, Aug. 29, 2022 (GLOBE NEWSWIRE) - Medigus Ltd. (Nasdaq: MDGS), a technology company engaged in advanced medical solutions, innovative internet technologies, and electric vehicle and charging solutions, announced |
|
| August 25, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of August 2022 Commission File Number 001-37381 MEDIGUS LTD. (Translation of registrant?s name into English) 3 HaNechoshet Street, Building B, 6971068, Israel (Address of principal executive offic |
